Provided by Tiger Trade Technology Pte. Ltd.

INTELLIGENT BIO SOLUTIONS INC

2.43
+0.03001.25%
Pre-market: 2.41-0.0200-0.82%09:04 EDT
Volume:5.04M
Turnover:13.42M
Market Cap:7.33M
PE:-0.29
High:2.84
Open:2.40
Low:2.05
Close:2.40
52wk High:24.90
52wk Low:1.52
Shares:3.02M
Float Shares:2.79M
Volume Ratio:151.17
T/O Rate:180.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.4407
EPS(LYR):-20.0407
ROE:-307.69%
ROA:-76.20%
PB:1.33
PE(LYR):-0.12

Loading ...

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry

THOMSON REUTERS
·
Jun 16

Intelligent Bio Solutions - Expects to Complete Interference Study by Mid-July 2026 for FDA 510(K) Submission

THOMSON REUTERS
·
Jun 16

Intelligent Bio Solutions to present at Planet MicroCap Conference

Reuters
·
Jun 04

Intelligent Bio Solutions initiates multi-site method comparison study

TIPRANKS
·
Jun 02

Intelligent Bio Solutions starts multi-site study supporting FDA 510(k) filing for codeine fingerprint drug test

Reuters
·
Jun 02

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(K) Submission

THOMSON REUTERS
·
Jun 02

Intelligent Bio Solutions Q3 Basic EPS USD -1.8

THOMSON REUTERS
·
May 13

Intelligent Bio Solutions Q3 EPS $(1.80) Up From $(4.40) YoY, Sales $1.060M Up From $728.867K YoY

Benzinga Earnings
·
May 13

Intelligent Bio Solutions Q3 FY26 net loss widens to $2.87 million; revenue rises 46% to $1.06 million

Reuters
·
May 13

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-Over-Year

THOMSON REUTERS
·
May 13

Press Release: Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Dow Jones
·
May 13

Intelligent Bio Solutions publishes investor presentation on fingerprint sweat drug screening system

Reuters
·
Apr 21

Intelligent Bio Solutions announces launch of validation study for IFDSS

TIPRANKS
·
Apr 20

BUZZ-Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing

Reuters
·
Apr 17

Intelligent Bio Solutions advances FDA 510(k) submission after penetration test finds no major flaws

Reuters
·
Apr 17

Intelligent Bio Solutions Advances Upcoming FDA 510(K) Submission, Successfully Completes Penetration Testing With No Major Vulnerabilities Identified

THOMSON REUTERS
·
Apr 17

BRIEF-Intelligent Bio Solutions Completes Clinical Cut-Off Study

Reuters
·
Apr 02

Intelligent Bio Solutions completes FDA 510(k) cut-off study for codeine fingerprint test

Reuters
·
Apr 02

Intelligent Bio Solutions Inc: Expects to Complete Method Comparison and Usability Study by End of June 2026

THOMSON REUTERS
·
Apr 02

Intelligent Bio Solutions Inc: NOW Initiated Second Phase of Its Clinical Study Program

THOMSON REUTERS
·
Apr 02